SAVE THE DATE:
You and your managed care medical director, pharmacy director,
physician, pharmacist, and clinician colleagues are invited to
A Managed Care 2023 CE/CME Symposium on
A Year 2023 Evidence- and Trial-Based CGM Best Pharmacy Practice
Update and Practical Roadmap
or Managed Care Pharmacists:
Overcoming Cost and Access Barriers in Payor Settings
to
Optimize Diabetes Care and Improve Patient Satisfaction
Save the Date and Time – Register Now!
Monday, October 16, 2023
Dinner and Registration: 6:00 PM – 6:30 PM
Clinical Program: 6:30 PM – 8:00 PM
Orlando Marriott World Center
Meeting Room: Canary 1 & 2
Award-Winning Diabetes-Focused CME for Your Mobile, Tablet or Laptop Platform
For more information:
info@cmeducation.net
Program Agenda
6:30 PM – 7:00 PM
Chair's Introduction
The Emerging Foundational Role of Sensor-Based CGM for Managing Diabetes:
New Trends in Medicare/Medicaid (CMS) Reimbursement for Continuous Glucose Monitoring in Insulin-Dependent Patients
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP – Program Chair
Endocrine Clinical Pharmacy Specialist CGM and Remote Monitoring Program Coordinator Cleveland Clinic Endocrinology and Metabolist Institute Cleveland, OH
7:15 PM – 7:40 PM
New Technologies and Device Improvements in CGM:
Focus on Device Accuracy and Use of Glucose Pattern Insight Reports (GPIR) to Efficiently Guide Care, Prevent Hypoglycemia, and Modify Therapy in Persons with Diabetes
Eugene Wright, MD
Consulting Associate, Departments of Medicine Duke University Medical Center Durham, NC Inaugural Chair, ADA Primary Care Interest Group Medical Director for Performance Improvement Charlotte Area Health Education Center Charlotte, NC
7:40 PM – 8:10 PM
Recent Trial, Pharmacoeconomic and Real World Data Supporting CGM as a Best Pharmacy Practice Strategy for Managing Persons with Diabetes
A Practical, Pharmacist-Based Roadmap for Deploying CGM in the Managed Care Setting
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP – Program Chair
Endocrine Clinical Pharmacy Specialist CGM and Remote Monitoring Program Coordinator Cleveland Clinic Endocrinology and Metabolist Institute Cleveland, OH
8:10 PM – 8:45 PM
Case-Based Strategies for Incorporating Sensor-Based CGM across the Diabetes Spectrum of Care: Incorporating Recommendations from AHRQ (Agency for Healthcare Research and Quality) for CGM-Based Management
Evidence for New Quality Metrics and Standards for Diabetes, Including TIR, GV, GMI and Real Time Glycemic Monitoring to Optimize Clinical Outcomes
Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
Professor of Pharmacy Practice, Clinical Pharmacist, Well Life Massachusetts College of Pharmacy and Heath Sciences Boston, MA
8:45 PM – 9;00 PM
Interactive Question and Answer Session
Evidence for New Quality Metrics and Standards for Diabetes, Including TIR, GV, GMI and Real Time Glycemic Monitoring to Optimize Clinical Outcomes
Program Chair and Distinguished Faculty
Program Chair and Distinguished Faculty
Diana Isaacs, PharmD, BCPS, BC-ADM, CDE — Program Chair
Clinical Pharmacy Specialist/CGM
Program Coordinator Department of Endocrinology, Diabetes & Metabolism
Cleveland Clinic Diabetes Center
Cleveland, OH
Eugene Wright, MD
Consulting Associate, Departments of Medicine
Duke University Medical Center Durham, NC
Inaugural Chair, ADA Primary Care Interest Group
Medical Director for Performance Improvement Charlotte Area Health Education Center
Charlotte, NC
Jennifer Goldman, PharmD, CDCES, BC‑ADM, FCCP
Professor of Pharmacy Practice, Clinical Pharmacist, Well Life
Massachusetts College of Pharmacy and Heath Sciences
Boston, MA
EDUCATIONAL AND LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
- Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for persons with diabetes within the managed care environment.
- Discuss new developments in CMS (Medicare and Medicaid) reimbursement for persons on insulin therapy.
- Better understand new technological advances in CGM devices with focus on AGP and Glucose Pattern Insight Reports.
- Analyze the rationale and evidence for pharmacists recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies in the managed care setting.
INTENDED AUDIENCE
This complimentary CE/CME educational activity is designed for all healthcare providers (HCPs) involved in developing, delivering, consulting, and monitoring care for patients with type 2 or type 1 diabetes, including pharmacists, endocrinologists, diabetes specialists, family medicine specialists, primary care physicians, physician associates, and related clinicians.
REGISTRATION
Participation in this activity is complimentary, and clinicians are invited to view this CE/CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
GRANTOR SUPPORT
This activity is supported by an independent medical education grant from Abbott Diabetes Care.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMEducation Resources. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CREDIT DESIGNATION
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-23-334-L01-P)
———